Carbon Dioxide Angiography in a Patient With Renal Failure
A 71-year-old woman with CKD stage 4 (eGFR 22 mL/min/1.73 m²) and a non-healing right toe ulcer is scheduled for diagnostic angiography and possible below-knee intervention. She has had prior contrast reactions (hives) and a documented iodinated contrast allergy. The interventionalist plans CO2 angiography for the diagnostic run and asks you to set up. You notice the CO2 cylinder is connected through a single manual syringe system, and the patient is on 2 L/min nasal cannula for mild COPD.
1. Identify equipment and patient-safety considerations specific to CO2 angiography that you must verify before the case.
Read the worked answer
Key CO2-specific checks:
- Gas delivery system integrity. CO2 angiography requires a medical-grade CO2 cylinder with a regulator and a closed, one-way delivery system (e.g., a dedicated CO2 injector or a properly assembled syringe/stopcock manifold). Verify no air can enter the line and that the system is purged of air before injection - air contamination is dangerous.
- Patient factors. CO2 is contraindicated or used with great caution in patients with severe pulmonary disease/CO2 retention, right-to-left shunts, or in the arterial supply to the brain, spine, or coronary arteries (risk of gas embolism to critical beds). Her COPD means you should flag this to the physician; mild COPD on 2 L O2 is usually acceptable but the physician should confirm and consider whether the patient retains CO2.
- Injection technique principles. CO2 is buoyant and compressible: it fills non-dependent vessels poorly, so positioning and injection volume/rate matter. Large volumes and high rates increase risk of gas trapping and discomfort. Use the minimum volume that opacifies, and avoid injecting into small distal vessels where gas can't clear.
- Monitoring. Watch for pain, nausea, and signs of gas embolism; have the patient report symptoms. Keep the delivery system closed and purge between uses.
Confirm all of this with the physician before the first injection rather than assuming the setup is correct.
2. The diagnostic CO2 run is nondiagnostic below the knee. How should the team reason about the next imaging/contrast step?
Read the worked answer
Reason from limitations of the modality and the patient's risk profile:
- Why CO2 underperforms distally. CO2 buoyancy and rapid solubility make it poor at opacifying small, dependent, below-knee runoff vessels; it can also cause transient discomfort. A nondiagnostic distal run is an expected limitation, not necessarily operator error.
- Options to improve the study: optimize positioning (elevate the limb so CO2 fills the vessel), use appropriate volume/rate, consider digital subtraction with stacking, or supplement with another modality (e.g., MR angiography if feasible, or duplex ultrasound) to map runoff before intervention.
- If iodinated contrast is considered: she has a documented allergy and CKD stage 4. That combination means premedication and a minimized-volume strategy, and the decision belongs to the physician with informed consent. Do not unilaterally switch to iodinated contrast.
- Document that the CO2 run was limited and why, so the record reflects the reasoning and the plan for runoff evaluation.
The judgment being tested: recognize modality limitations, protect the renal/allergic patient, and escalate the decision rather than improvising.